Rheumatoid arthritis and the incidence of influenza and influenza-related complications: A retrospective cohort study

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Blumentals, William A ^a   Arreglado, Anna ^a   Napalkov, Pavel ^b   Toovey, Stephen ^c,d  

^a HOFFMANN LA ROCHE INC   (United States)

^b GENENTECH INC   (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; INFLUENZA VACCINE; LEFLUNOMIDE; MINOCYCLINE; PENICILLAMINE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DRUG USE; FEMALE; HEART INFARCTION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PNEUMONIA; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEASONAL INFLUENZA;

EID: 84865311008     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-158     Document Type: Article

References (26)

1. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE, Arthritis Rheum 2002 46 2287 2293 10.1002/art.10524 12355475
2. Vaccination in patients with chronic rheumatic or autoimmune diseases. Glück T, Müller-Ladner U, Clin Infect Dis 2008 46 1459 1465 10.1086/587063 18419456 (Pubitemid 351589953)
3. Infection in rheumatoid arthritis. Baum J, Arthritis Rheum 1971 14 135 137 10.1002/art.1780140119 5542366
4. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Goldenberg DL, Arthritis Rheum 1989 32 496 502 10.1002/anr.1780320422 2650687 (Pubitemid 19118679)
5. How to reduce morbidity and mortality from chest infections in rheumatoid arthritis. Housden MM, Bell G, Heycock CR, Hamilton J, Saravanan V, Kelly CA, Clin Med 2010 10 326 329 20849003
6. Postlicensure reports of infection during use of etanercept and infliximab [abstract]. Gershon S, Wise RP, Niu M, Siegel J, Arthritis Rheum 2000 43 2857
7. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Baghai M, Osmon DR, Wolk DM, Wold LE, Haidukewych GJ, Matteson EL, Mayo Clin Proc 2001 76 653 656 11393506 (Pubitemid 32525142)
8. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Lee JH, Slifman NR, Gershon SK, Edwards ET, Schwieterman WD, Siegel JN, Wise RP, Brown SL, Udall JN Jr, Braun MM, Arthritis Rheum 2002 46 2565 2570 10.1002/art.10583 12384912 (Pubitemid 36118917)
9. Identification of new risk factors for pneumonia: population-based case-control study. Vinogradova Y, Hippisley-Cox J, Coupland C, Br J Gen Pract 2009 59 329 e338 19843413
10. Department of Health, PL CMO (2005)1: the Pneumococcal Immunisation Programme for Older People and Risk Groups London: Department of Health 2009 http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/ Professionalletters/Chiefmedicalofficerletters/DH-4107903
11. Mayo Clinic, Influenza (flu). Risk factors. 21 August 2010 http://www.mayoclinic.com/health/influenza/DS00081/DSECTION=risk-factors
12. Thomson Reuters, Pharmaceuticals: Data, Databases and Online Tools: Marketscan Research Databases New York, NY, USA: Thomson Reuters 2011 http://thomsonreuters.com/products-services/healthcare/healthcare-products/ pharmaceuticals/mktscan-res-db/
13. Centers for Disease Control and Prevention, Classification of diseases, functioning, and disability. International Classification of Diseases, Ninth Revision (ICD-9) Atlanta, GA, USA: CDC 2009 http://www.cdc.gov/nchs/icd/icd9.htm
14. Use of glucocorticoids and risk of infections. Cutolo M, Seriolo B, Pizzorni C, Secchi ME, Soldano S, Paolino S, Montagna P, Sulli A, Autoimmun Rev 2008 8 153 155 10.1016/j.autrev.2008.07.010 18703175
15. Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Ruyssen-Witrand A, Fautrel B, Saraux A, Le-Loët X, Pham T, Joint Bone Spine 2010 77 246 251 10.1016/j.jbspin.2010. 02.009 20451437
16. Infectious complications in SLE after immunosuppressive therapies. Kang I, Park SH, Curr Opin Rheumatol 2003 15 528 534 10.1097/00002281-200309000-00002 12960476 (Pubitemid 37041388)
17. Chinese Critical Care Clinical Trial Group: Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing China: risk factors for hospital mortality. Xi X, Xu Y, Jiang L, Li A, Duan J, Du B, BMC Infect Dis 2010 10 256 20799934
18. Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. Mitchell WS, Brooks PM, Stevenson RD, Buchanan WW, J Rheumatol 1976 3 124 133 950628
19. Acute septic arthritis complicating chronic rheumatoid arthritis. Rimoin DL, Wennberg JE, JAMA 1966 196 617 621 10.1001/jama.1966.03100200057018 5952288
20. T cell homeostasis in patients with rheumatoid arthritis. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM, Proc Natl Acad Sci U S A 2000 97 9203 9208 10.1073/pnas.97.16.9203 10922071 (Pubitemid 30626698)
21. Infections and treatment of patients with rheumatic diseases. Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C, Sulli A, Valesini G, Sarzi-Puttini P, Clin Exp Rheumatol 2008 26 Suppl 48 67 S73 18799057
22. The risk of infections with biologic therapies for rheumatoid arthritis. Furst DE, Semin Arthritis Rheum 2010 39 327 346 10.1016/j.semarthrit.2008.10.002 19117595
23. FDA, US Food and Drug Administration: Tumor Necrosis Factor-alpha (TNFα) Blockers: Label Change-Boxed Warning Updated for Risk of Infection from Legionella and Listeria including Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab). FDA 2011 http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm270977.htm 22870484
24. Implications of reduced seroprotection (SP) after pandemic H1N1 (2009) influenza adjuvant-free vaccination in patients with rheumatoid arthritis on active systemic treatment (classical and biologic DMARDS). Ribeiro A, Guedes L, Moraes J, Saad C, Aikawa N, Calish A, França I, Gonçalves C, Sampaio-Barros P, Carvalho J, Borba E, Timenetsky M, Precioso A, Duarte A, Bonfa E, Laurindo I, Ann Rheum Dis 2011 70 Suppl 3 117 20980283
25. Centers for Disease Control and Prevention, Arthritis and Influenza Update 2010-2011 Atlanta, GA, USA: CDC 14 September 2010. http://www.cdc.gov/ arthritis/flu.htm
26. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention (CDC), MMWR Recomm Rep 2010 59 1 62 21160459